Bicycle Therapeutics plc

NASDAQ:BCYC

Biotechnology

Healthcare
$3.11 -1.36%

-$0.06 today

Market cap
$217.99M
Beta
1.54
P/E (TTM)
-1.3
EPS (TTM)
-$3.14
52W Low $3.95High $9.18

Volume 0.57M

Average 0.49M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$249.68M

FY 2025 · Annual

Investing Cash Flow

-$2.35M

FY 2025 · Annual

Financing Cash Flow

-$131,000.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(66.82M)(112.72M)(180.66M)(169.03M)(218.96M)
Depreciation & Amortization1.41M3.69M6.55M7.17M6.42M
Deferred Income Tax(1.67M)(4.98M)3.31M(5.23M)(850K)
Stock-Based Compensation12.08M26.78M32.48M38.08M39.46M
Change in Working Capital38.07M672K76.66M(33.46M)(75.75M)
Accounts Receivables4.54M(11.35M)(1.2M)(11.95M)2.89M
Inventory(4.79M)0000
Accounts Payables1.2M2.56M8M3.1M(6.87M)
Other Working Capital37.12M9.46M69.86M(24.61M)(71.77M)
Other Non-Cash Items2.14M442K1.04M(2.26M)0
Operating Cash Flow(14.79M)(86.11M)(60.63M)(164.72M)(249.68M)
Capital Expenditures(2.03M)(18.99M)(2.93M)(1.24M)(2.36M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00005.49K
Investing Cash Flow(2.03M)(18.99M)(2.93M)(1.24M)(2.35M)
Debt Repayment15M00(31.91M)0
Common Stock Issued298.54M5.7M249.35M544.13M37.09K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities7.18M989K682K7.53M(168.09K)
Financing Cash Flow320.73M6.69M250.03M519.75M(131K)
Effect of Forex Changes(1.21M)(1.12M)1.35M(694K)804K
Net Change in Cash302.69M(99.53M)187.82M353.1M(251.35M)
Free Cash Flow(16.82M)(105.1M)(63.56M)(165.96M)(252.61M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$219.0M
+ D&A$6.4M
+ Stock-Based Comp$39.5M
- Deferred Tax-$850.0K
- Working Capital-$75.8M
+ Other Non-Cash$0
= Operating Cash Flow-$249.7M
- Capex-$2.4M
= Free Cash Flow-$252.6M

Analysis

FY2025 free cash flow is -$252.6M. FCF conversion is 115.4% of net income. Operating cash flow was -$249.7M, with capex of -$2.4M. The largest bridge item is Working Capital at -$75.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportOct 29, 2026
8-KCurrent reportOct 29, 2026
4/A4/A filingOct 7, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
4Statement of changes in beneficial ownershipOct 6, 2026

Does BCYC generate free cash flow?

Bicycle Therapeutics plc (BCYC) generated -$252.61M of free cash flow in fiscal 2025.

How much operating cash flow does BCYC produce?

Operating cash flow was -$249.68M, before capital expenditures of $2.36M.